Enriched cancer pathway | Genes under regulation | P value |
Ras signaling pathway |
10 genes: FGF1, FGF2, FGF7, EGFR, GAB1, RASAL2, RHOA, RGL1, PLD1, PRKCA
|
3.195e-05 |
Axon guidance |
6 genes: NFAT5, NTNG1, ARHGEF12, RHOA, PLXNA2, SEMA6D
|
0.000812 |
Vascular smooth muscle contraction |
5 genes: ADCY2, ARHGEF12, RHOA, PRKCA, CALD1
|
0.002986 |
MAPK signaling pathway |
7 genes: EGFR, FGF1, FGF2, FGF7, PRKCA, TAOK1, MAP3K13
|
0.007635 |
Regulation of actin cytoskeleton |
6 genes: EGFR, FGF1, FGF2, FGF7, ARHGEF12, RHOA
|
0.009537 |
PI3K AKT signaling pathway |
8 genes: FGF1, FGF2, FGF7, EGFR, PDPK1, PRKAA2, PRKCA, CDK6
|
0.009792 |
GnRH signaling pathway |
4 genes: ADCY2, EGFR, PLD1, PRKCA
|
0.01044 |
Calcium signaling pathway |
5 genes: ADCY2, EGFR, PDE1C, PRKCA, SLC8A1
|
0.01697 |
Adipocytokine signaling pathway |
3 genes: PPARGC1A, PRKAA2, PRKAB2
|
0.01959 |
Adherens junction |
3 genes: EGFR, FER, RHOA
|
0.02359 |
Insulin signaling pathway |
4 genes: PPARGC1A, PDPK1, PRKAA2, PRKAB2
|
0.02919 |
ErbB signaling pathway |
3 genes: EGFR, GAB1, PRKCA
|
0.03695 |
Wnt signaling pathway |
4 genes: NFAT5, PRICKLE2, RHOA, PRKCA
|
0.03869 |
Gap junction |
3 genes: ADCY2, EGFR, PRKCA
|
0.04023 |
Aldosterone.regulated sodium reabsorption |
2 genes: PDPK1, PRKCA
|
0.04851 |